While T cells observed in white matter lesions of MOGAD39 have been shown to be primarily CD4+ (in contrast to MS lesions, which are CD8+ T-cell dominant38,51), we did not find differences in CSF frequencies of CD4+ T cells or CD8+ T cells between MS and MOGAD patients. The gene discussed is CD4; the disease is myeloid sarcoma.